THE URGENT NEED
There is a need for innovation in respiratory symptom care management.
More than 99.2 million people are living with asthma, COPD, lung cancer, and allergic rhinitis in the US.
The yearly cost of COPD, asthma, allergic rhinitis, and lung cancer is $147.5B in both indirect and direct medical costs lost productivity, long term symptom management and early deaths each year.
OUR INNOVATIVE SOLUTION
Leverage signal processing and AI to classify coughs and changes in voices with respiratory diseases
CanAIry is a platform that monitors the respiratory health for people suffering from chronic respiratory disesase using our proprietary classifier model.
Our team came together during the MIT NYC Grand Hackathon this past November. While we all met for the first time, our group instantly gelled. Over the course of 48 hours, we were able to rapidly develop and prototype an idea to detect people affected with early stage lung cancer. We won first place for best overall hack in lung cancer. Since then we have been working together daily to refine our existing prototype and extensively research opportunities to develop our product: CanAIry.